Trials / Completed
CompletedNCT01076478
Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Otsuka Pharmaceutical, Inc., Philippines · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To describe if there are differences in the subjective, objective and electrophysiologic parameters of diabetic polyneuropathies at baseline, four (4) weeks, eight (8) weeks, and twelve (12) weeks after Cilostazol therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cilostazol | 100 mg, 200mg tablet Cilostazol |
Timeline
- Start date
- 2004-03-01
- Completion
- 2009-11-01
- First posted
- 2010-02-26
- Last updated
- 2010-02-26
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT01076478. Inclusion in this directory is not an endorsement.